Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Hims and Hers Health Inc (HIMS) vs Hyperliquid Strategies Inc Common Stock (PURR) Price & Performance

Hims and Hers Health IncTrade
Hyperliquid Strategies Inc Common StockTrade

Price performance (Past 24H)

Key statistics

Hims and Hers Health Inc vs Hyperliquid Strategies Inc Common Stock — how do they compare? Hims and Hers Health Inc trades at $29.33 (market cap $6.55B), while Hyperliquid Strategies Inc Common Stock trades at $11.35 (market cap $2.24B). The key difference: Hims and Hers Health Inc is far larger — about 2.9× Hyperliquid Strategies Inc Common Stock's market cap, and Hyperliquid Strategies Inc Common Stock is trading nearer its 52-week high, Hims and Hers Health Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Hims and Hers Health Inc for 21 Days and Hyperliquid Strategies Inc Common Stock for 0 Days on average.

HIMSPURR
Market Cap
$6.55B$2.24B
Volume
14,842,81414,135,020
Sector
HealthFinancials
52-Week High
$62.76$14.09
52-Week Low
$14.52$3.10
Typical Hold Time
21 Days0 Days
Enterprise Value
$7.25B$2.10B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Hims and Hers Health Inc

Hims & Hers Health (HIMS) trades at $29.38, down 0.54% on the day, amid a bearish technical signal and mixed earnings history. The company reported revenue of $2.35 billion in 2025 with a net income of $128.37 million, but 2026 projections show a net loss of $142 million. Valuation ratios are elevated with a P/E of 57.14 and EV/EBITDA of 205.86. Recent news highlights multiple securities class action lawsuits filed against the company, creating investor uncertainty.

The outlook is cautious due to profitability concerns and legal risks. Analyst consensus is a Hold with a $32.17 price target, suggesting limited upside. Key risks include ongoing litigation, negative profit margins, and high valuation multiples. Investment appeal hinges on the company's ability to return to profitability and navigate regulatory challenges.

Hyperliquid Strategies Inc Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

HIMS
86% Buy14% Sell
Avg holding period · 21 Days
PURR
100% Buy0% Sell
Avg holding period · 0 Days

About Hims and Hers Health Inc

Hims & Hers is a multi-specialty telehealth platform that provides personalized health and wellness products. It offers access to medical providers and treatments for hair loss, sexual health, and skincare.

Read more on HIMS →

About Hyperliquid Strategies Inc Common Stock

Hyperliquid Strategies is a digital asset treasury company focused on managing a treasury of HYPE tokens, the native digital assets of the Hyperliquid Layer-1 blockchain.

Read more on PURR →